— Know what they know.
Not Investment Advice
Also trades as: 4502.T (JPX) · $vol 168M · TKPHF (OTC) · $vol 0M

TAK NYSE

Takeda Pharmaceutical Company Limited
1W: +4.2% 1M: +10.7% 3M: +16.6% YTD: +30.8% 1Y: +45.3% 3Y: +52.9% 5Y: +73.7%
$20.27
-0.16 (-0.78%)
After Hours: $20.30 (+0.04, +0.17%)
Weekly Expected Move ±3.0%
$19 $20 $20 $21 $21
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Strong Buy · Power 73 · $65.0B mcap · 3.16B float · 0.094% daily turnover · Short 29% of daily vol
Credit Risk of going bust: lower than 78% of companies Debt: 32.5% of company value Bonds: $208.5M held by 194 funds, 85 bp over Treasuries → details ▾
If the stock fell to about $0.49 (down 98%), Takeda Pharmaceutical Company Limited would be worth roughly what it owes.
Total debt $31.37B against a stock market value of $65.02B.
Distance to default 9.16 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $17.34B (short-term plus half of long-term), stock volatility 21.6%; Altman Z'' 1.53. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
Analyst Recommendations
Strong Buy: 0Buy: 5Hold: 1Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$—
Analysts0

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B-
Oct 27, 2026
DCF
4
ROE
2
ROA
3
D/E
1
P/E
1
P/B
4
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. TAK receives an overall rating of B-. Strongest factors: DCF (4/5), P/B (4/5). Areas of concern: ROE (2/5), D/E (1/5), P/E (1/5).
Rating Change History
DateFromTo
2026-10-22 B B-
2026-09-10 B+ B
2026-09-09 B B+
2026-08-28 B+ B
2026-08-26 B B+
2026-08-19 B+ B
2026-08-10 B B+
2026-07-01 B+ B
2026-05-14 B B+
2026-04-01 B+ B

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ — Grade A
Profitability
41
Balance Sheet
43
Earnings Quality
70
Growth
59
Value
—
Momentum
87
Safety
—
Cash Flow
53

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
—
—
Piotroski F-Score
6/9
✓ ✓ ✓ ✓ ✓ ✗ ✗ ✓ ✗
Beneish M-Score
-2.33
Unlikely Manipulator
Ohlson O-Score
-10.84
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
BB+
Score: 46.7/100
Trend: Deteriorating
Earnings Quality
100/100
OCF/NI: 4.86x
Accruals: -4.7%
The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. TAK scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. TAK's score of -2.33 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. TAK's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. TAK receives an estimated rating of BB+ (score: 46.7/100), with a deteriorating trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). TAK's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
56.09x
PEG
1.82x
P/S
2.21x
P/B
1.32x
P/FCF
—
P/OCF
—
EV/EBITDA
—
EV/Revenue
—
EV/EBIT
—
EV/FCF
—
Earnings Yield
—
FCF Yield
—
Shareholder Yield
—
Graham Number
$1734.06
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 56.1x earnings, TAK is priced for high growth expectations. Graham's intrinsic value formula yields $1734.06 per share, suggesting a potential 8388% margin of safety at the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.665
NI / EBT
×
Interest Burden
0.463
EBT / EBIT
×
EBIT Margin
0.127
EBIT / Rev
×
Asset Turnover
0.314
Rev / Assets
×
Equity Multiplier
2.057
Assets / Equity
=
ROE
2.5%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. TAK's ROE of 2.5% is driven by Asset Turnover (0.314), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
15.00%
Fair P/E
38.50x
Intrinsic Value
$2184.92
Price/Value
—
Margin of Safety
—
Premium
—
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with TAK's realized 15.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. TAK trades at a premium to its adjusted intrinsic value of $2184.92, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 38.5x compares to the current market P/E of 56.1x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$20.29
Median 1Y
$21.21
5th Pctile
$14.61
95th Pctile
$30.95
Ann. Volatility
22.5%
25th–75th percentile 5th–95th percentile Median path Historical

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
47,029
-0.9% YoY
Revenue / Employee
—
Profit / Employee
—
SGA / Employee
—
Avg labor cost proxy

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE 9.5% 8.8% 4.2% 3.4% 3.5% 4.8% 5.3% 4.6% 2.8% 2.8% 2.1% 2.0% 4.1% 2.9% 1.5% 1.9% 0.5% 1.5% 2.6% 2.5% 2.53%
ROA 3.8% 3.5% 1.8% 1.5% 1.6% 2.1% 2.3% 2.1% 1.3% 1.3% 1.0% 1.0% 2.0% 1.4% 0.7% 0.9% 0.2% 0.8% 1.3% 1.2% 1.23%
ROIC 6.5% 6.2% 3.8% 3.0% 3.1% 4.1% 4.1% 3.8% 3.1% 3.4% 5.0% 4.7% 4.3% 3.1% 1.9% 2.4% 0.8% 1.8% 3.0% 2.9% 2.85%
ROCE 5.6% 5.2% 4.5% 3.4% 3.5% 4.4% 4.8% 4.4% 3.1% 2.2% 3.0% 2.8% 5.0% 4.2% 3.3% 3.7% 3.0% 4.9% 4.8% 4.6% 4.58%
Gross Margin 67.4% 68.8% 64.7% 69.9% 69.5% 69.4% 67.6% 69.7% 67.1% 65.8% 63.1% 68.0% 66.5% 63.6% 63.7% 65.2% 65.8% 54.4% 48.8% 66.7% 66.66%
Operating Margin 11.5% 12.9% -0.2% 15.5% 10.4% 13.4% 9.3% 15.9% -4.7% 9.4% -1.0% 13.8% 15.7% 5.9% -7.1% 16.7% 6.2% 16.0% 4.3% 16.5% 16.51%
Net Margin 5.4% 6.4% -1.3% 10.8% 6.2% 10.9% 3.3% 8.4% -4.6% 9.5% -0.3% 7.9% 7.8% 2.1% -9.8% 11.2% -1.1% 8.7% -2.2% 9.3% 9.28%
EBITDA Margin 28.6% 29.5% 15.0% 38.0% 28.6% 33.2% 20.9% 34.6% 19.4% 23.1% 24.7% 32.2% 32.3% 16.9% 17.2% 39.7% 28.4% 37.6% 14.2% 27.7% 27.67%
FCF Margin 22.9% 26.0% 26.3% 22.2% 21.0% 20.7% 8.5% 4.4% 3.1% -3.1% 6.0% 12.4% 14.2% 20.0% 18.7% 19.7% 22.1% 21.3% 16.7% 14.8% 14.82%
OCF Margin 30.0% 33.1% 31.5% 29.0% 27.4% 26.8% 24.3% 24.0% 23.2% 17.5% 16.8% 18.0% 19.3% 24.3% 23.1% 24.6% 27.2% 26.2% 21.4% 19.0% 19.00%
ROE 3Y Avg snapshot only 2.11%
ROE 5Y Avg snapshot only 2.76%
ROA 3Y Avg snapshot only 1.02%
ROIC 3Y Avg snapshot only 1.52%
ROIC Economic snapshot only 2.75%
Cash ROA snapshot only 5.65%
Cash ROIC snapshot only 7.40%
CROIC snapshot only 5.77%
NOPAT Margin snapshot only 7.32%
Pretax Margin snapshot only 5.87%
R&D / Revenue snapshot only 15.15%
SGA / Revenue snapshot only 24.15%
SBC / Revenue snapshot only 0.79%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio — — — — — — — — — — — — — — — — — — — — 56.094
P/S Ratio — — — — — — — — — — — — — — — — — — — — 2.207
P/B Ratio — — — — — — — — — — — — — — — — — — — — 1.325
P/FCF — — — — — — — — — — — — — — — — — — — — —
P/OCF — — — — — — — — — — — — — — — — — — — — —
EV/EBITDA — — — — — — — — — — — — — — — — — — — — —
EV/Revenue — — — — — — — — — — — — — — — — — — — — —
EV/EBIT — — — — — — — — — — — — — — — — — — — — —
EV/FCF — — — — — — — — — — — — — — — — — — — — —
Earnings Yield — — — — — — — — — — — — — — — — — — — — —
FCF Yield — — — — — — — — — — — — — — — — — — — — —
PEG Ratio snapshot only 1.821
Graham Number snapshot only $1734.06
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 1.28 1.37 1.21 1.18 1.15 1.16 0.97 0.99 1.04 1.06 1.11 1.26 1.28 1.31 1.01 1.16 1.36 1.19 1.27 1.14 1.140
Quick Ratio 0.87 0.92 0.81 0.75 0.75 0.75 0.57 0.56 0.55 0.55 0.58 0.74 0.77 0.72 0.52 0.59 0.76 0.65 0.70 0.62 0.616
Debt/Equity 0.79 0.82 0.76 0.73 0.71 0.69 0.69 0.69 0.66 0.69 0.67 0.70 0.73 0.65 0.65 0.66 0.65 0.64 0.63 0.65 0.654
Net Debt/Equity 0.68 0.68 0.61 0.62 0.58 0.58 0.60 0.63 0.61 0.64 0.60 0.59 0.60 0.58 0.59 0.60 0.55 0.54 0.55 0.58 0.584
Debt/Assets 0.34 0.34 0.33 0.33 0.32 0.32 0.31 0.32 0.31 0.33 0.32 0.34 0.35 0.32 0.32 0.32 0.32 0.31 0.32 0.32 0.315
Debt/EBITDA 3.66 3.82 4.04 4.56 4.50 3.73 3.60 3.91 4.13 4.55 4.47 4.95 3.93 3.96 3.95 3.77 4.11 3.49 3.58 3.90 3.896
Net Debt/EBITDA 3.11 3.16 3.22 3.90 3.71 3.09 3.14 3.60 3.84 4.24 4.03 4.18 3.23 3.53 3.60 3.42 3.46 2.94 3.14 3.48 3.480
Interest Coverage 2.36 2.42 3.13 2.89 2.74 2.62 2.93 2.78 2.73 2.09 3.02 3.03 3.13 4.25 2.97 2.52 1.92 1.97 1.73 1.86 1.863
Equity Multiplier 2.36 2.38 2.32 2.23 2.17 2.19 2.20 2.14 2.10 2.11 2.08 2.08 2.11 2.04 2.05 2.04 2.03 2.02 1.99 2.07 2.072
Cash Ratio snapshot only 0.191
Debt Service Coverage snapshot only 3.997
Cash to Debt snapshot only 0.107
FCF to Debt snapshot only 0.140
Defensive Interval snapshot only 242.0 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.27 0.28 0.27 0.27 0.28 0.30 0.30 0.29 0.28 0.30 0.29 0.28 0.31 0.31 0.31 0.30 0.30 0.29 0.31 0.31 0.314
Inventory Turnover 1.34 1.36 1.38 1.36 1.37 1.43 1.35 1.27 1.24 1.29 1.30 1.27 1.31 1.31 1.30 1.25 1.25 1.28 1.44 1.42 1.421
Receivables Turnover 4.26 4.60 5.39 4.52 4.68 5.54 6.75 5.29 5.48 5.75 7.18 5.70 6.25 6.30 7.25 6.31 6.36 6.19 6.07 5.84 5.840
Payables Turnover 3.36 3.10 4.19 3.11 3.28 3.39 4.12 2.94 3.24 3.13 4.56 3.29 3.71 3.36 5.03 3.55 3.67 3.66 4.71 4.40 4.401
DSO 86 79 68 81 78 66 54 69 67 63 51 64 58 58 50 58 57 59 60 62 62.5 days
DIO 272 269 265 269 267 255 270 288 294 283 280 288 278 278 280 291 292 285 253 257 256.8 days
DPO 109 118 87 117 111 108 89 124 113 117 80 111 98 109 73 103 99 100 77 83 82.9 days
Cash Conversion Cycle 249 231 246 232 233 214 235 233 248 230 251 241 239 227 258 246 250 244 236 236 236.3 days
Fixed Asset Turnover snapshot only 2.176
Operating Cycle snapshot only 319.3 days
Cash Velocity snapshot only 8.834
Capital Intensity snapshot only 3.361
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 5.6% 8.3% 11.6% 7.4% 10.2% 13.8% 12.8% 14.5% 10.8% 5.7% 5.9% 7.3% 9.4% 9.8% 7.5% 1.5% -2.8% -2.0% -0.7% 4.0% 4.02%
Net Income 7.4% 1.4% -38.8% -54.2% -54.9% -37.4% 37.8% 52.7% -10.1% -35.1% -54.6% -50.3% 51.3% 16.7% -25.1% -8.7% -88.6% -44.8% 79.1% 33.1% 33.07%
EPS 7.4% 1.4% -38.9% -54.2% -54.5% -37.2% 34.6% 51.7% -10.2% -35.7% -53.2% -51.0% 47.1% 16.8% -25.7% -8.6% -88.4% -45.4% 81.3% 31.7% 31.69%
FCF 56.0% 48.4% 21.0% 0.6% 1.5% -9.4% -63.3% -77.4% -83.6% -1.2% -25.6% 2.0% 4.0% 8.1% 2.4% 62.1% 51.0% 4.3% -11.6% -21.9% -21.86%
EBITDA 59.6% 35.2% 9.4% -8.5% -9.0% 0.9% 13.2% 20.5% 7.5% -10.9% -11.0% -8.9% 13.5% 19.1% 5.4% 7.9% -12.1% 14.1% 19.9% 6.2% 6.21%
Op. Income 2.1% 1.1% -9.5% -38.6% -42.2% -34.7% 6.4% 40.2% -4.1% -21.9% -56.4% -58.3% 25.5% 30.3% 60.0% 70.3% -44.9% -8.5% 44.5% 41.9% 41.89%
OCF Growth snapshot only -19.66%
Asset Growth snapshot only 11.84%
Equity Growth snapshot only 10.09%
Debt Growth snapshot only 9.63%
Shares Change snapshot only 1.04%
Dividend Growth snapshot only 0.94%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 24.3% 24.9% 19.4% 12.9% 9.2% 6.8% 7.0% 8.2% 8.8% 9.2% 10.1% 9.7% 10.2% 9.7% 8.7% 7.6% 5.6% 4.4% 4.1% 4.2% 4.25%
Revenue 5Y 14.2% 14.9% 15.6% 15.5% 16.3% 17.2% 17.9% 18.3% 18.6% 18.5% 15.2% 12.1% 9.6% 7.2% 6.8% 6.7% 6.5% 7.0% 7.3% 6.9% 6.85%
EPS 3Y 18.8% 25.7% 28.0% 1.7% 1.4% — 3.8% 41.8% 50.9% -0.6% -27.3% -30.2% -15.6% -22.2% -22.4% -12.1% -46.4% -25.7% -14.3% -16.2% -16.16%
EPS 5Y 9.3% 10.6% -0.2% -9.0% -8.1% -6.3% -3.9% 4.7% -7.3% -4.3% 5.7% 70.5% 78.2% — 1.1% 5.0% -10.1% -9.0% -12.3% -16.4% -16.37%
Net Income 3Y 49.8% 58.4% 28.2% 1.7% 1.4% — 3.9% 41.7% 50.6% -0.4% -27.4% -29.7% -15.1% -22.0% -22.3% -11.5% -46.3% -25.2% -15.2% -15.5% -15.46%
Net Income 5Y 25.8% 27.1% 14.9% 4.3% 5.5% 7.6% 11.1% 20.2% 6.4% 10.0% 5.7% 71.1% 79.3% — 1.1% 5.3% -10.0% -8.7% -12.5% -15.8% -15.83%
EBITDA 3Y 49.6% 48.4% 33.2% 25.9% 20.2% 20.2% 24.5% 17.3% 16.0% 6.7% 3.3% 0.2% 3.6% 2.3% 2.0% 5.8% 2.4% 6.6% 4.0% 1.4% 1.42%
EBITDA 5Y 23.8% 23.9% 24.2% 19.1% 19.9% 21.8% 24.1% 31.6% 26.8% 24.1% 19.0% 17.0% 16.2% 13.0% 12.6% 9.6% 9.3% 10.6% 6.8% 2.8% 2.85%
Gross Profit 3Y 22.8% 22.9% 19.6% 13.7% 10.9% 8.9% 8.3% 8.8% 8.8% 8.4% 8.7% 7.5% 8.0% 7.4% 6.8% 6.0% 3.7% 1.0% -1.5% -1.1% -1.08%
Gross Profit 5Y 14.7% 15.5% 16.0% 15.1% 15.6% 16.4% 16.9% 17.4% 17.2% 16.7% 14.5% 12.0% 9.8% 7.4% 6.5% 5.6% 5.3% 4.7% 3.8% 3.2% 3.21%
Op. Income 3Y 52.8% 44.3% 31.0% 46.3% 64.3% 1.5% 1.3% 36.7% 19.7% 1.8% -25.1% -28.9% -11.4% -12.7% -9.4% -0.2% -12.8% -2.4% 0.3% 0.2% 0.23%
Op. Income 5Y 28.5% 27.7% 24.2% 12.9% 10.1% 9.0% 15.2% 28.4% 14.6% 8.9% 0.9% 12.8% 39.8% 75.6% 52.4% 12.6% 3.5% 4.7% -0.6% -2.8% -2.81%
FCF 3Y 51.1% 59.6% 68.9% 44.1% 25.5% 26.7% -8.7% -27.8% -36.2% — -30.9% -11.8% -5.9% 0.5% -3.0% 3.4% 7.4% 5.4% 30.2% 56.3% 56.33%
FCF 5Y — — 44.4% 37.9% 37.8% 28.3% 6.6% -2.8% -10.5% — 5.6% 15.3% 10.1% 17.9% 13.6% 13.0% 14.4% 9.5% -0.4% -2.7% -2.74%
OCF 3Y 45.8% 50.5% 50.7% 36.5% 23.1% 20.7% 13.4% 12.3% 10.2% -2.8% -10.8% -8.4% -4.9% -1.0% -2.0% 1.9% 5.3% 3.5% -0.1% -3.5% -3.50%
OCF 5Y 89.0% — 33.9% 29.5% 26.6% 23.0% 20.9% 23.4% 24.0% 16.8% 16.9% 14.2% 9.7% 13.1% 9.6% 9.7% 10.7% 8.1% -0.8% -3.0% -3.01%
Assets 3Y 43.2% 30.1% -1.7% 1.3% 4.2% 1.2% 2.9% 5.5% 6.2% 5.0% 5.4% 8.6% 5.1% 6.0% 2.6% -0.1% -0.3% 4.5% 3.6% 1.9% 1.92%
Assets 5Y 27.0% 25.1% 24.8% 26.5% 27.2% 25.1% 27.7% 28.9% 28.3% 19.8% 1.7% 3.7% 2.5% 3.0% 2.1% 2.1% 3.1% 4.6% 3.7% 4.4% 4.35%
Equity 3Y 34.9% 37.8% 3.3% 9.1% 11.3% 8.2% 10.4% 13.9% 14.9% 13.3% 12.0% 14.2% 9.1% 11.6% 6.9% 2.8% 2.0% 7.4% 7.1% 3.0% 2.98%
Book Value 3Y 7.0% 9.4% 3.1% 9.2% 11.3% 7.9% 9.1% 13.9% 15.1% 13.1% 12.1% 13.3% 8.5% 11.4% 6.7% 2.1% 1.7% 6.7% 8.3% 2.1% 2.12%
Dividend 3Y -20.7% -20.7% -0.1% -0.1% -0.2% -0.5% -1.7% 0.1% -0.2% 0.8% 1.0% 0.8% 1.2% 1.3% 1.6% 1.0% 1.3% 1.2% 2.0% -0.2% -0.18%
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.84 0.79 0.87 0.95 0.96 0.90 0.90 0.93 0.95 0.96 0.98 0.99 0.99 0.94 0.96 0.95 0.92 0.93 0.93 0.93 0.935
Earnings Stability 0.15 0.20 0.19 0.21 0.18 0.28 0.30 0.40 0.17 0.27 0.14 0.14 0.24 0.15 0.00 0.06 0.05 0.28 0.57 0.56 0.556
Margin Stability 0.96 0.96 0.99 0.98 0.97 0.97 0.97 0.97 0.97 0.97 0.98 0.97 0.97 0.97 0.98 0.97 0.97 0.96 0.93 0.93 0.933
Rev. Growth Consistency 1.00 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 1.00 1.000
Earn. Growth Consistency 1.00 1.00 0.00 0.00 0.00 0.00 0.50 0.50 0.00 0.00 0.00 0.00 0.50 0.50 0.00 0.00 0.00 0.00 0.50 0.50 0.500
FCF Positive Streak 1 1 1 1 1 1 1 1 1 0 1 1 1 0 1 1 1 1 1 1 1
Earnings Persistence 0.50 0.50 0.84 0.50 0.50 0.85 0.85 0.50 0.96 0.86 0.50 0.50 0.50 0.93 0.90 0.97 0.50 0.82 0.50 0.87 0.868
Earnings Smoothness 0.00 0.17 0.52 0.26 0.24 0.54 0.68 0.58 0.89 0.57 0.25 0.33 0.59 0.85 0.71 0.91 0.00 0.42 0.43 0.72 0.716
ROE Trend 0.08 0.07 0.00 -0.02 -0.02 -0.02 -0.01 -0.01 -0.03 -0.04 -0.03 -0.02 0.01 -0.01 -0.02 -0.01 -0.03 -0.01 0.01 0.00 0.005
Gross Margin Trend 0.03 0.03 0.01 -0.01 -0.01 -0.01 0.00 0.00 -0.01 -0.02 -0.03 -0.02 -0.02 -0.03 -0.02 -0.03 -0.03 -0.04 -0.07 -0.06 -0.064
FCF Margin Trend 0.08 0.10 0.07 0.03 0.02 -0.02 -0.17 -0.19 -0.19 -0.26 -0.11 -0.01 0.02 0.11 0.11 0.11 0.13 0.13 0.04 -0.01 -0.012
Sustainable Growth Rate 3.8% 3.1% -1.0% -1.4% -1.1% -0.1% 0.6% 0.3% -1.3% -1.7% -2.1% -2.0% -0.1% -1.3% -2.7% -2.4% -3.9% -2.7% -1.6% -1.9% -1.85%
Internal Growth Rate 1.5% 1.3% — — — — 0.3% 0.1% — — — — — — — — — — — — —
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 2.15 2.62 4.88 5.27 4.82 3.86 3.08 3.27 5.03 4.10 4.97 5.30 3.02 5.35 9.80 8.05 36.32 10.25 5.04 4.86 4.862
FCF/OCF 0.76 0.79 0.83 0.77 0.77 0.77 0.35 0.18 0.13 -0.18 0.36 0.69 0.74 0.82 0.81 0.80 0.82 0.81 0.78 0.78 0.780
FCF/Net Income snapshot only 3.792
OCF/EBITDA snapshot only 0.698
CapEx/Revenue 7.1% 7.1% 5.2% 6.7% 6.4% 6.1% 15.7% 19.6% 20.1% 20.6% 10.8% 5.6% 5.0% 4.3% 4.4% 4.9% 5.0% 4.9% 4.8% 4.2% 4.18%
CapEx/Depreciation snapshot only 0.288
Accruals Ratio -0.04 -0.06 -0.07 -0.06 -0.06 -0.06 -0.05 -0.05 -0.05 -0.04 -0.04 -0.04 -0.04 -0.06 -0.06 -0.06 -0.08 -0.07 -0.05 -0.05 -0.047
Sloan Accruals snapshot only -0.043
Cash Flow Adequacy snapshot only 1.734
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield — — — — — — — — — — — — — — — — — — — — 3.15%
Dividend/Share $89.59 $89.43 $90.01 $90.23 $90.20 $89.03 $86.57 $89.87 $89.19 $91.00 $91.55 $92.68 $91.52 $95.23 $95.63 $97.50 $98.03 $99.61 $99.53 $98.42 $101.00
Payout Ratio 59.9% 64.2% 1.2% 1.4% 1.3% 1.0% 88.1% 93.3% 1.5% 1.6% 2.0% 2.0% 1.0% 1.5% 2.8% 2.3% 9.4% 2.8% 1.6% 1.7% 1.73%
FCF Payout Ratio 36.4% 31.2% 30.3% 35.1% 35.7% 34.2% 81.4% 1.6% 2.2% — 1.1% 54.0% 45.5% 32.9% 35.3% 35.0% 31.6% 33.4% 41.1% 45.7% 45.73%
Total Payout Ratio 60.4% 76.2% 1.6% 1.9% 1.8% 1.2% 96.6% 94.1% 1.5% 1.6% 2.0% 2.0% 1.0% 1.5% 3.3% 3.0% 12.4% 3.7% 1.9% 1.7% 1.74%
Div. Increase Streak 0 0 1 0 0 0 0 0 0 0 0 1 0 1 1 1 1 1 1 1 1
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield — — — — — — — — — — — — — — — — — — — — —
Net Buyback Yield — — — — — — — — — — — — — — — — — — — — —
Total Shareholder Return — — — — — — — — — — — — — — — — — — — — —
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 0.90 0.90 0.76 0.84 0.89 1.00 0.84 0.85 0.99 1.20 2.71 2.76 1.08 0.89 0.62 0.72 0.34 0.55 0.74 0.67 0.665
Interest Burden (EBT/EBIT) 0.88 0.86 0.61 0.57 0.56 0.55 0.68 0.66 0.51 0.56 0.14 0.14 0.44 0.43 0.46 0.43 0.27 0.33 0.42 0.46 0.463
EBIT Margin 0.17 0.16 0.14 0.11 0.11 0.13 0.14 0.13 0.09 0.06 0.09 0.09 0.13 0.12 0.08 0.10 0.08 0.14 0.14 0.13 0.127
Asset Turnover 0.27 0.28 0.27 0.27 0.28 0.30 0.30 0.29 0.28 0.30 0.29 0.28 0.31 0.31 0.31 0.30 0.30 0.29 0.31 0.31 0.314
Equity Multiplier 2.50 2.51 2.40 2.31 2.26 2.28 2.25 2.18 2.14 2.15 2.13 2.11 2.10 2.07 2.07 2.06 2.07 2.03 2.02 2.06 2.057
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $149.68 $139.22 $73.00 $63.49 $68.16 $87.41 $98.22 $96.29 $61.21 $56.22 $45.93 $47.17 $90.06 $65.64 $34.11 $43.09 $10.47 $35.80 $61.82 $56.75 $56.75
Book Value/Share $1684.34 $1692.57 $1803.19 $2031.94 $2146.44 $1966.35 $1968.72 $2211.14 $2258.47 $2126.63 $2318.54 $2453.79 $2149.26 $2340.15 $2192.41 $2161.37 $2260.17 $2386.37 $2498.35 $2354.89 $2418.72
Tangible Book/Share $-802.99 $-834.50 $-806.96 $-849.81 $-789.38 $-726.15 $-838.49 $-886.61 $-841.08 $-777.98 $-768.72 $-724.15 $-624.20 $-648.54 $-638.88 $-583.42 $-507.21 $-507.67 $-467.55 $-535.97 $-535.97
Revenue/Share $1076.12 $1100.37 $1132.42 $1155.40 $1198.85 $1255.91 $1247.85 $1314.22 $1327.04 $1315.06 $1359.19 $1388.60 $1411.80 $1444.49 $1448.38 $1410.50 $1400.03 $1399.74 $1455.16 $1452.14 $1477.99
FCF/Share $246.00 $286.46 $297.33 $256.81 $252.31 $260.32 $106.42 $57.75 $41.28 $-40.70 $81.42 $171.52 $201.16 $289.30 $270.73 $278.27 $309.92 $298.48 $242.31 $215.20 $224.07
OCF/Share $322.36 $364.62 $356.35 $334.70 $328.81 $337.19 $302.76 $314.79 $307.68 $230.72 $228.35 $249.91 $272.14 $351.30 $334.21 $347.03 $380.22 $366.89 $311.47 $275.92 $286.35
Cash/Share $200.46 $238.71 $277.63 $213.76 $265.41 $231.34 $171.56 $117.76 $106.63 $100.12 $150.75 $269.86 $281.43 $166.17 $128.22 $131.97 $234.45 $237.74 $191.24 $164.38 $168.82
EBITDA/Share $365.89 $361.86 $341.52 $324.43 $336.69 $366.33 $377.60 $388.36 $361.50 $323.30 $345.76 $348.34 $399.08 $385.18 $361.36 $375.90 $358.22 $434.76 $438.40 $395.10 $395.10
Debt/Share $1338.68 $1382.57 $1378.77 $1480.41 $1514.53 $1364.89 $1357.80 $1516.61 $1494.67 $1471.24 $1544.07 $1724.60 $1568.66 $1526.86 $1427.43 $1418.59 $1472.40 $1515.36 $1568.97 $1539.20 $1539.20
Net Debt/Share $1138.22 $1143.86 $1101.14 $1266.65 $1249.12 $1133.55 $1186.24 $1398.85 $1388.04 $1371.12 $1393.33 $1454.74 $1287.23 $1360.69 $1299.21 $1286.62 $1237.95 $1277.62 $1377.73 $1374.81 $1374.81
Per Employee
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Employee Count snapshot only 47,029
Revenue/Employee snapshot only $99099624.40
Income/Employee snapshot only $3872912.31
EBITDA/Employee snapshot only $26963494.72
FCF/Employee snapshot only $14686079.02
Assets/Employee snapshot only $333055582.73
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — —
Piotroski F-Score 6 7 5 5 7 7 7 6 5 4 6 5 6 8 6 6 6 4 7 6 6
Beneish M-Score -2.52 -2.78 -2.82 -2.76 -2.76 -2.67 -2.74 -2.63 -2.70 -2.65 -2.58 -2.67 -2.75 -2.74 -2.79 -2.95 -2.88 -2.69 -2.34 -2.33 -2.335
Ohlson O-Score snapshot only -10.836
Net-Net WC snapshot only $-1543.61
EVA snapshot only $-855788044689.95
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only BB+
Credit Score 51.75 53.25 55.50 47.70 47.70 49.20 46.95 46.05 45.90 45.00 49.95 51.30 54.30 54.30 49.20 49.20 48.05 46.70 48.05 46.70 46.700
Credit Grade snapshot only 11
Credit Trend snapshot only -2.500
Implied Spread (bps) snapshot only 400.000

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms